γ-H2AX foci formation as a pharmacodynamic marker of DNA damage produced by DNA cross-linking agents: results from 2 phase I clinical trials of SJG-136 (SG2000).

Wu J, Clingen PH, Spanswick VJ, Mellinas-Gomez M, Meyer T, Puzanov I, Jodrell D, Hochhauser D, Hartley JA
Clin Cancer Res. 2013 19 (3): 721-30

PMID: 23251007 · PMCID: PMC6485439 · DOI:10.1158/1078-0432.CCR-12-2529

MeSH Terms (9)

Benzodiazepinones Comet Assay DNA Damage Fibroblasts Histones Humans Lymphocytes Pharmacogenetics Pyrroles

Connections (1)

This publication is referenced by other Labnodes entities:

Links